نتائج البحث - "Angiotensin II Type 1 Receptor Blockers/adverse effects/therapeutic use"

1

Academic Journal

New studies on hypertension of great significance to clinical practice. Also very old persons benefit from blood pressure reduction / Nya hypertonistudier av stor betydelse för klinisk praxis. Även mycket gamla har nytta av blodtryckssänkning

المؤلفون: Nilsson, P M

المصدر: Läkartidningen. 105(19):1382

View record in SveMed+

Full Text Finder

2

Academic Journal

Olmesartan for the delay or prevention of microalbuminuria in type 2 diabetes

المؤلفون: Haller H, Ito S, Izzo JL Jr, Januszewicz A, Katayama S, Menne J, Mimran A, Rabelink TJ, Ritz E, Ruilope LM, Rump LC, Viberti G, ROADMAP Trial Investigators

المساهمون: SCHEEN, André

المصدر: New England Journal of Medicine, 364, 907-917 (2011)

مصطلحات موضوعية: Albuminuria/epidemiology/*prevention & control, Angiotensin II Type 1 Receptor Blockers/adverse effects/*therapeutic use, Blood Pressure/drug effects, Cardiovascular Diseases/epidemiology/etiology/mortality, Coronary Disease/complications, Diabetes Mellitus, Type 2/complications/*drug therapy, Human health sciences, Endocrinology, metabolism & nutrition, Urology & nephrology, Sciences de la santé humaine, Endocrinologie, métabolisme & nutrition, Urologie & néphrologie

Relation: http://www.nejm.org/; urn:issn:0028-4793; urn:issn:1533-4406; https://orbi.uliege.be/handle/2268/98960; info:hdl:2268/98960; https://orbi.uliege.be/bitstream/2268/98960/1/Olmesartan%20for%20the%20Delay%20or%20Prevention.pdf; info:pmid:21388309

الاتاحة: https://orbi.uliege.be/handle/2268/98960
https://orbi.uliege.be/bitstream/2268/98960/1/Olmesartan%20for%20the%20Delay%20or%20Prevention.pdf
https://doi.org/10.1056/NEJMoa1007994

View record in BASE

3

Academic Journal

Effect of valsartan on the incidence of diabetes and cardiovascular events.

المؤلفون: McMurray, John J, Holman, Rury R, Haffner, Steven M, Bethel, M Angelyn, Holzhauer, Bjorn, Hua, Tsushung A, Belenkov, Yuri, Boolell, Mitradev, Buse, John B, Buckley, Brendan M, Chacra, Antonio R, Chiang, Fu*-Tien, Charbonnel, Bernard, Chow, Chun*-Chung, Davies, Melanie J, Deedwania, Prakash, Diem, Peter, Einhorn, Daniel, Fonseca, Vivian, Fulcher, Gregory R, Gaciong, Zbigniew, Gaztambide, Sonia, Giles, Thomas, Horton, Edward, Ilkova, Hasan, Jenssen, Trond, Kahn, Steven E, Krum, Henry, Laakso, Markku, Leiter, Lawrence A, Levitt, Naomi S, Mareev, Viacheslav, Martinez, Felipe, Masson, Chantal, Mazzone, Theodore, Meaney, Eduardo, Nesto, Richard, Pan, Changyu, Prager, Rudolf, Raptis, Sotirios A, Rutten, Guy E H M, Sandstroem, Herbert, Schaper, Frank, Scheen, André, Schmitz, Ole, Sinay, Isaac, Soska, Vladimir, Stender, Steen, Tamas, Gyula, Tognoni, Gianni, Tuomilehto, Jaako, Villamil, Alberto S, Vozar, Juraj, Califf, Robert M

المصدر: New England Journal of Medicine, 362 (16), 1477-90 (2010)

مصطلحات موضوعية: Angiotensin II Type 1 Receptor Blockers/adverse effects/therapeutic use, Blood Glucose/analysis/drug effects, Blood Pressure/drug effects, Body Weight/drug effects, Cardiovascular Diseases/epidemiology/mortality/prevention & control, Cyclohexanes/therapeutic use, Diabetes Mellitus, Type 2/epidemiology/prevention & control, Double-Blind Method, Drug Therapy, Combination, Exercise, Female, Follow-Up Studies, Glucose Intolerance/diet therapy/drug therapy/therapy, Humans, Hypoglycemic Agents/therapeutic use, Incidence, Male, Middle Aged, Phenylalanine/analogs & derivatives/therapeutic use, Proportional Hazards Models, Risk Factors, Tetrazoles/adverse effects/therapeutic use, Valine/adverse effects/analogs & derivatives/therapeutic use, Human health sciences, Endocrinology, metabolism & nutrition, Cardiovascular & respiratory systems, Pharmacy

Relation: http://www.nejm.org; urn:issn:0028-4793; urn:issn:1533-4406; https://orbi.uliege.be/handle/2268/25987; info:hdl:2268/25987; https://orbi.uliege.be/bitstream/2268/25987/1/Effect%20of%20Valsartan%20on%20the%20Incidence.pdf; info:pmid:20228403

الاتاحة: https://orbi.uliege.be/handle/2268/25987
https://orbi.uliege.be/bitstream/2268/25987/1/Effect%20of%20Valsartan%20on%20the%20Incidence.pdf
https://doi.org/10.1056/NEJMoa1001121

View record in BASE

4

Irbesartan reduces common carotid artery intima-media thickness in hypertensive patients when compared with atenolol: the Swedish Irbesartan Left Ventricular Hypertrophy Investigation versus Atenolol (SILVHIA) study

المؤلفون: Mörtsell, David, Malmqvist, K, Held, Claes, Kahan, T

المصدر: Journal of Internal Medicine. 261(5):472-479

وصف الملف: print

URL الوصول: https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-17365
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Retrieve&list_uids=17444886&dopt=Citation

5

Relationship of dose of background angiotensin-converting enzyme inhibitor to the benefits of candesartan in the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM)-Added trial

المؤلفون: McMurray, J. J., Young, J. B., Dunlap, M. E., Granger, C. B., Hainer, J., Michelson, E. L., Earle, S., Olofsson, B., Ostergren, J., Yusuf, S., Swedberg, Karl, 1944, Pfeffer, M. A.

المصدر: American heart journal. 151(5):985-91

URL الوصول: https://gup.ub.gu.se/publication/50148

6

The effect of losartan versus atenolol on cardiovascular morbidity and mortality in patients with hypertension taking aspirin: the Losartan Intervention for Endpoint Reduction in hypertension (LIFE) study

المؤلفون: Fossum, E., Moan, A., Kjeldsen, S. E., Devereux, R. B., Julius, S., Snapinn, S. M., Edelman, J. M., de Faire, U., Fyhrquist, F., Ibsen, H., Kristianson, K., Lederballe-Pedersen, O., Lindholm, L. H., Nieminen, M. S., Omvik, P., Oparil, S., Wedel, H., Dahlöf, Björn, 1953

المصدر: J Am Coll Cardiol. 46(5):770-5

مصطلحات موضوعية: Medical and Health Sciences, Medicin och hälsovetenskap, Adrenergic beta-Antagonists/adverse effects/*therapeutic use, Aged, Angiotensin II Type 1 Receptor Blockers/adverse effects/*therapeutic use, Aspirin/adverse effects/*therapeutic use, Atenolol/adverse effects/*therapeutic use, Drug Interactions, Drug Therapy, Combination, Female, Humans, Hypertension/complications/*drug therapy, Hypertrophy, Left Ventricular/complications/*drug therapy, Losartan/adverse effects/*therapeutic use, Male, Treatment Outcome

URL الوصول: https://gup.ub.gu.se/publication/55868

7

Academic Journal

Effect of Valsartan on the Incidence of Diabetes and Cardiovascular Events

المؤلفون: Califf, Robert M., McMurray, John J., Holman, Rury R., Haffner, Steven M., Bethel, M. Angelyn, Holzhauer, Björn, Hua, Tsushung A., Belenkov, Yuri, Boolell, Mitradev, Buse, John B., Buckley, Brendan M., Chacra, Antonio R., Chiang, Fu Tien, Charbonnel, Bernard, Chow, Chun Chung, Davies, Melanie J., Deedwania, Prakash, Diem, Peter, Einhorn, Daniel, Fonseca, Vivian, Fulcher, Gregory R., Gaciong, Zbigniew, Gaztambide, Sonia, Giles, Thomas, Horton, Edward, Ilkova, Hasan, Jenssen, Trond, Kahn, Steven E., Krum, Henry, Laakso, Markku, Leiter, Lawrence A., Levitt, Naomi S., Mareev, Viacheslav, Martinez, Felipe, Masson, Chantal, Mazzone, Theodore, Meaney, Eduardo, Nesto, Richard, Pan, Changyu, Prager, Rudolf, Raptis, Sotirios A., Rutten, Guy E.H.M., Sandstroem, Herbert, Schaper, Frank, Scheen, Andre, Schmitz, Ole, Sinay, Isaac, Soska, Vladimir, Stender, Steen, Tamás, Gyula, Tognoni, Gianni, Tuomilehto, Jaako, Villamil, Alberto S., Vozár, Juraj

المساهمون: School of Medicine

المصدر: The New England Journal of Medicine, 362(16)

مصطلحات موضوعية: Follow-Up Studies, Glucose Intolerance/diet therapy/drug therapy/therapy, Combination, Hypoglycemic Agents/therapeutic use, Body Weight/drug effects, Diabetes Mellitus, Humans, Cardiovascular Diseases/epidemiology/mortality/prevention & control, Blood Glucose/analysis/drug effects, Type 2/epidemiology/prevention & control, Drug Therapy, Cyclohexanes/therapeutic use, Double-Blind Method, Blood Pressure/drug effects, Inciden, Female, Angiotensin II Type 1 Receptor Blockers/adverse effects/therapeutic use, Exercise

Relation: https://doi.org/10.17615/ypnd-nk38; https://cdr.lib.unc.edu/downloads/sb397j600?file=thumbnail; https://cdr.lib.unc.edu/downloads/sb397j600

الاتاحة: https://doi.org/10.17615/ypnd-nk38
https://cdr.lib.unc.edu/downloads/sb397j600?file=thumbnail
https://cdr.lib.unc.edu/downloads/sb397j600

View record in BASE

8

Academic Journal

Renin-angiotensin system blockade and contrast-induced renal toxicity

المؤلفون: Saudan, Patrick, Mueller, Hajo, Feraille, Eric, Martin, Pierre-Yves, Mach, FranÃ§ois

المصدر: ISSN: 1121-8428 ; JN. Journal of Nephrology, vol. 21, no. 5 (2008) p. 681-685.

مصطلحات موضوعية: info:eu-repo/classification/ddc/616, Angiotensin II Type 1 Receptor Blockers/adverse effects/therapeutic use, Angiotensin-Converting Enzyme Inhibitors/adverse effects/therapeutic use, Contrast Media/adverse effects, Coronary Angiography, Female, Glomerular Filtration Rate/drug effects, Humans, Kidney/drug effects, Male, Middle Aged, Radioisotope Renography, Renal Blood Flow, Effective/drug effects

Relation: info:eu-repo/semantics/altIdentifier/pmid/18949722; https://archive-ouverte.unige.ch/unige:1948; unige:1948

الاتاحة: https://archive-ouverte.unige.ch/unige:1948

View record in BASE

9

Academic Journal

Aliskiren reduces blood pressure and suppresses plasma renin activity in combination with a thiazide diuretic, an angiotensin-converting enzyme inhibitor, or an angiotensin receptor blocker

المؤلفون: O'Brien, E., Barton, J., Nussberger, J., Mulcahy, D., Jensen, C., Dicker, P., Stanton, A.

المصدر: Hypertension, vol. 49, no. 2, pp. 276-84

مصطلحات موضوعية: Adult Aged Aged, 80 and over Angiotensin II Type 1 Receptor Blockers/adverse effects/*therapeutic use Angiotensin-Converting Enzyme Inhibitors/adverse effects/*therapeutic use Antihypertensive Agents/adverse effects/blood/*therapeutic use Biphenyl Compounds/adverse effects/therapeutic use Blood Pressure/drug effects Blood Pressure Monitoring, Ambulatory Drug Therapy, Combination Female Fumarates/adverse effects/blood/*therapeutic use Humans Hydrochlorothiazide/adverse effects/therapeutic use Hypertension/blood/diagnosis/*drug therapy/physiopathology Male Middle Aged Patient Compliance Ramipril/adverse effects/therapeutic use Renin/*antagonists & inhibitors/blood Sodium Chloride Symporter Inhibitors/adverse effects/*therapeutic use Tetrazoles/adverse effects/therapeutic use

Relation: info:eu-repo/semantics/altIdentifier/pmid/17159081; info:eu-repo/semantics/altIdentifier/eissn/1524-4563; https://serval.unil.ch/notice/serval:BIB_BA99C2BAFA0F

الاتاحة: https://serval.unil.ch/notice/serval:BIB_BA99C2BAFA0F
https://doi.org/10.1161/01.HYP.0000253780.36691.4f

View record in BASE